A second law firm is likely to throw its hat in the ring to run a competing class action against Qantas over flight cancellations in the COVID-19 pandemic, but a judge has made orders trying to side-step a carriage fight, criticising them as “wasteful and expensive”.
Wealth manager Escala Partners has failed in its bid to restrain two senior financial advisors who defected to rival Crestone from working in wealth management and soliciting its clients.
The future of a competition class action against AGL Energy is in doubt after being abandoned by its funder, despite evading the energy supplier’s bid to dismiss the case.
With bated breath class action litigators and funders have waited for this day, when the Full Federal Court decides the question of power to make common fund orders at settlement. They aren’t the final arbiters, but the judges’ ruling may be no less important for that.
Despite an influx of data breach class actions and a large number of competing proceedings, the past financial year has seen the lowest number of new class actions filed in six years, according to a new report.
A decision by federal environment minister Tanya Pibersek to greenlight the extension of two mega coal mines in NSW was “legally open” to her, a judge has ruled, despite acknowledging the “existential threat” of climate change.
A judge has approved the settlement of a class action brought on behalf of sovereign bondholders over the disclosure of climate change risks, despite a late scrap with the government over whether the deal puts a stop to future cases.
The Australian Securities and Investments Commission is seeking to restrain payday lenders Cigno and BSF Solutions from enforcing loan fees against 10,000 customers.
A former flight attendant trainee has filed a lawsuit against fly-in fly-out operator Alliance Airlines, which was the subject of a takeover bid by Qantas earlier this year, claiming he was dismissed for complaining of harassment.
An Australian law firm is investigating a class action against drug manufacturers over a commonly prescribed antibiotic said to cause “disabling” side effects, including nerve damage and psychosis.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
